Vialwirebiotech, curated
July 19, 2026, 1:35 PM
July 17, 2026
- 12:00 PM · BioWorld12:00 PMJune’s $25.7B M&A haul caps biopharma’s record-breaking first half — BioWorld
- 12:00 PM · BioWorld12:00 PMDanaher’s Leica to buy Statlab to expand pathology footprint — BioWorld
- 12:00 PM · BioWorld12:00 PMOpen-label extension drives home benefits of Insmed’s PAH therapy — BioWorld
- 10:07 AM · BioPharma Dive10:07 AMArbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances — BioPharma Dive
- 9:21 AM · BioPharma Dive9:21 AMGSK shelves cough drug acquired in $2B deal — BioPharma Dive
- 9:17 AM · Pharmaceutical Executive9:17 AM<![CDATA[Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMMirador licenses Kira’s long-acting anti-C5a antibody KP-301 — BioWorld
- 9:00 AM · BioWorld9:00 AMValerio to collaborate with Abivax, outlines pipeline progress — BioWorld
- 6:42 AM · Pharmaceutical Technology6:42 AMBayer’s heart failure drug bound for NHS on NICE recommendation — Pharmaceutical Technology
- 6:18 AM · Pharmaceutical Technology6:18 AMFDA grants traditional approval to Novartis’ Fabhalta for IgAN — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMDNA Script expands access to DNA synthesis platform in India — Drug Discovery World
- 4:30 AM · STAT News
July 16, 2026
- 2:12 PM · FT — Pharmaceuticals2:12 PMDassault Systèmes in talks to buy drug trial software company for about $2bn — FT — Pharmaceuticals
- 12:00 PM · BioWorld12:00 PMCLIA regs may be in for an update — BioWorld
- 12:00 PM · BioWorld12:00 PMUS FDA approves Merck's Lipfendra, first oral PCSK9 for LDL-C — BioWorld
- 12:00 PM · BioWorld12:00 PMIndustry hits back as rebate on drugs more than doubles in Germany — BioWorld
- 12:00 PM · BioWorld12:00 PMAdvancell raises $315M to power global isotope strategy — BioWorld
- 12:00 PM · BioWorld12:00 PMAbbott raises FY2026 guidance, bullish on CGM, electrophysiology — BioWorld
- 11:30 AM · Drug Discovery World11:30 AMProstate cancer therapy gets MHRA marketing authorisation — Drug Discovery World
- 11:19 AM · BioPharma Dive11:19 AMVeradermics keeps ‘momentum going’ as baldness drug helps women with hair loss — BioPharma Dive
- 10:28 AM · Pharmaceutical Technology10:28 AMNovo secures European approval for oral Wegovy to extend lead over Lilly — Pharmaceutical Technology
- 9:43 AM · NYT — Health9:43 AMThe F.D.A. Approves a New Pill to Slash Cholesterol Levels — NYT — Health
- 9:00 AM · BioWorld9:00 AMFosun cleared to conduct clinical trials with FXR-0906 — BioWorld
- 9:00 AM · BioWorld9:00 AMTempest advances next-generation in vivo CAR T pipeline — BioWorld
- 9:00 AM · BioWorld9:00 AMAscletis to develop fixed-dose combination of ASC-48 and ASC-30 — BioWorld
- 7:28 AM · STAT News7:28 AMSTAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley — STAT News
- 6:30 AM · STAT News6:30 AMSTAT+: Amylyx nears pivotal endocrine drug study readout — STAT News
- 5:12 AM · Pharmaceutical Technology5:12 AMTelix opens radiopharmaceutical facility in Australia for cancer treatment — Pharmaceutical Technology
- 4:59 AM · Pharmaceutical Technology4:59 AMHarbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy — Pharmaceutical Technology
- 2:00 AM · SCMP — Tech2:00 AMChina’s lab monkey prices hit Covid-era highs on new drug R&D demand — SCMP — Tech
July 15, 2026
- 11:03 PM · SCMP — Tech11:03 PMMainland China funds increase stakes in Hong Kong biotech amid surge of licensing deals — SCMP — Tech